Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Human Milk Oligosaccharides (HMO) Market Report 2017

  • QYR2250580
  • 97 Pages
  • November 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Human Milk Oligosaccharides (HMO) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Human Milk Oligosaccharides (HMO) in these regions, from 2012 to 2022 (forecast).

United States Human Milk Oligosaccharides (HMO) market competition by top manufacturers/players, with Human Milk Oligosaccharides (HMO) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Abbott

Inbiose

Company two

Jennewein Biotechnologie

Glycom

ZuChem

Dextra Laboratories

...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Neutral HMOs

Acidic HMOs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Milk Oligosaccharides (HMO) for each application, including

Food Industry

Laboratory Research

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Human Milk Oligosaccharides (HMO) Market Report 2017

1 Human Milk Oligosaccharides (HMO) Overview

1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)

1.2 Classification of Human Milk Oligosaccharides (HMO) by Product Category

1.2.1 United States Human Milk Oligosaccharides (HMO) Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Human Milk Oligosaccharides (HMO) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Neutral HMOs

1.2.4 Acidic HMOs

1.3 United States Human Milk Oligosaccharides (HMO) Market by Application/End Users

1.3.1 United States Human Milk Oligosaccharides (HMO) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Food Industry

1.3.3 Laboratory Research

1.4 United States Human Milk Oligosaccharides (HMO) Market by Region

1.4.1 United States Human Milk Oligosaccharides (HMO) Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)

1.4.3 Southwest Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)

1.4.5 New England Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)

1.4.6 The South Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)

1.4.7 The Midwest Human Milk Oligosaccharides (HMO) Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Human Milk Oligosaccharides (HMO) (2012-2022)

1.5.1 United States Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2012-2022)

1.5.2 United States Human Milk Oligosaccharides (HMO) Revenue and Growth Rate (2012-2022)

2 United States Human Milk Oligosaccharides (HMO) Market Competition by Players/Suppliers

2.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Human Milk Oligosaccharides (HMO) Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Human Milk Oligosaccharides (HMO) Average Price by Players/Suppliers (2012-2017)

2.4 United States Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends

2.4.1 United States Human Milk Oligosaccharides (HMO) Market Concentration Rate

2.4.2 United States Human Milk Oligosaccharides (HMO) Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Human Milk Oligosaccharides (HMO) Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share by Region (2012-2017)

3.2 United States Human Milk Oligosaccharides (HMO) Revenue and Market Share by Region (2012-2017)

3.3 United States Human Milk Oligosaccharides (HMO) Price by Region (2012-2017)

4 United States Human Milk Oligosaccharides (HMO) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2012-2017)

4.3 United States Human Milk Oligosaccharides (HMO) Price by Type (2012-2017)

4.4 United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Type (2012-2017)

5 United States Human Milk Oligosaccharides (HMO) Sales (Volume) by Application (2012-2017)

5.1 United States Human Milk Oligosaccharides (HMO) Sales and Market Share by Application (2012-2017)

5.2 United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Human Milk Oligosaccharides (HMO) Players/Suppliers Profiles and Sales Data

6.1 Abbott

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Inbiose

6.2.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Company two

6.3.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Company two Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Jennewein Biotechnologie

6.4.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Glycom

6.5.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 ZuChem

6.6.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Dextra Laboratories

6.7.2 Human Milk Oligosaccharides (HMO) Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

...

7 Human Milk Oligosaccharides (HMO) Manufacturing Cost Analysis

7.1 Human Milk Oligosaccharides (HMO) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Human Milk Oligosaccharides (HMO) Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Human Milk Oligosaccharides (HMO) Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Human Milk Oligosaccharides (HMO) Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Human Milk Oligosaccharides (HMO) Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Type (2017-2022)

11.3 United States Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Application (2017-2022)

11.4 United States Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Human Milk Oligosaccharides (HMO)

Figure United States Human Milk Oligosaccharides (HMO) Market Size (MT) by Type (2012-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Type (Product Category) in 2016

Figure Neutral HMOs Product Picture

Figure Acidic HMOs Product Picture

Figure United States Human Milk Oligosaccharides (HMO) Market Size (MT) by Application (2012-2022)

Figure United States Sales Market Share of Human Milk Oligosaccharides (HMO) by Application in 2016

Figure Food Industry Examples

Table Key Downstream Customer in Food Industry

Figure Laboratory Research Examples

Table Key Downstream Customer in Laboratory Research

Figure United States Human Milk Oligosaccharides (HMO) Market Size (Million USD) by Region (2012-2022)

Figure The West Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales (MT) and Growth Rate (2012-2022)

Figure United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Human Milk Oligosaccharides (HMO) Market Major Players Product Sales Volume (MT) (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales (MT) of Key Players/Suppliers (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Human Milk Oligosaccharides (HMO) Sales Share by Players/Suppliers

Figure 2017 United States Human Milk Oligosaccharides (HMO) Sales Share by Players/Suppliers

Figure United States Human Milk Oligosaccharides (HMO) Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Human Milk Oligosaccharides (HMO) Revenue Share by Players/Suppliers

Figure 2017 United States Human Milk Oligosaccharides (HMO) Revenue Share by Players/Suppliers

Table United States Market Human Milk Oligosaccharides (HMO) Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)

Figure United States Market Human Milk Oligosaccharides (HMO) Average Price (USD/Kg) of Key Players/Suppliers in 2016

Figure United States Human Milk Oligosaccharides (HMO) Market Share of Top 3 Players/Suppliers

Figure United States Human Milk Oligosaccharides (HMO) Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Human Milk Oligosaccharides (HMO) Product Category

Table United States Human Milk Oligosaccharides (HMO) Sales (MT) by Region (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales Share by Region (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Share by Region (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Region in 2016

Table United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Revenue Share by Region (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in 2016

Table United States Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Region (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales (MT) by Type (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales Share by Type (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Share by Type (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Type in 2016

Table United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Human Milk Oligosaccharides (HMO) by Type (2012-2017)

Figure Revenue Market Share of Human Milk Oligosaccharides (HMO) by Type in 2016

Table United States Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Types (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Type (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales (MT) by Application (2012-2017)

Table United States Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Market Share by Application in 2016

Table United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Application (2012-2017)

Figure United States Human Milk Oligosaccharides (HMO) Sales Growth Rate by Application (2012-2017)

Table Abbott Basic Information List

Table Abbott Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Abbott Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure Abbott Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure Abbott Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table Inbiose Basic Information List

Table Inbiose Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Inbiose Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure Inbiose Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure Inbiose Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table Company two Basic Information List

Table Company two Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Company two Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure Company two Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure Company two Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table Jennewein Biotechnologie Basic Information List

Table Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table Glycom Basic Information List

Table Glycom Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Glycom Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure Glycom Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure Glycom Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table ZuChem Basic Information List

Table ZuChem Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure ZuChem Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure ZuChem Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure ZuChem Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table Dextra Laboratories Basic Information List

Table Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales Growth Rate (2012-2017)

Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales Market Share in United States (2012-2017)

Figure Dextra Laboratories Human Milk Oligosaccharides (HMO) Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Human Milk Oligosaccharides (HMO)

Figure Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)

Figure Human Milk Oligosaccharides (HMO) Industrial Chain Analysis

Table Raw Materials Sources of Human Milk Oligosaccharides (HMO) Major Players/Suppliers in 2016

Table Major Buyers of Human Milk Oligosaccharides (HMO)

Table Distributors/Traders List

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) and Growth Rate Forecast (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Price (USD/Kg) Trend Forecast (2017-2022)

Table United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Type (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Type (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Type in 2022

Table United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Application (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Application (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Application in 2022

Table United States Human Milk Oligosaccharides (HMO) Sales Volume (MT) Forecast by Region (2017-2022)

Table United States Human Milk Oligosaccharides (HMO) Sales Volume Share Forecast by Region (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume Share Forecast by Region (2017-2022)

Figure United States Human Milk Oligosaccharides (HMO) Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370